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ABSTRACT 
Although a low serum folate concentration is a useful biomarker of pure folate deficiency, 
the coexistence of either vitamin-B12 deficiency and/or hemolysis predictably raises serum 
folates. Therefore in resource-limited settings where dietary folate deficiency can coexist 
with vitamin-B12 deficiency and/or malaria, the serum folate concentration can be normal-
to-high, leading to serious underestimation of tissue-folate status. This review traces the 
genesis of an inappropriate overreliance on results of the serum folate concentration to rule 
out folate deficiency in such vulnerable populations of women and children; of significance, 
without due consideration of a chronically inadequate dietary folate intake, these 
populations have likely been wrongly judged to have an adequate folate status in influential 
studies. Through repetition, this error has led to a dangerous entry into the contemporary 
medical literature that folate deficiency is rare in these populations! As a consequence of 
this apologue, many millions of such women and children with mild-to-moderate tissue 
folate deficiency may have been deprived of folate replacement. This review uses historical 
documents to challenge earlier conclusions and re-emphasizes the need for contextual 
integration of clinical information in resource-limited settings.  
 
Introduction 
Food-fortification with folic acid has markedly reduced the incidence of folate deficiency and 
neural-tube defects wherever flour is centrally processed and equitably distributed to the general 
population.1,2 However, despite such initiatives in several developed and developing countries, 
for a variety of reasons2,3 up to 90% of the world’s women who primarily reside in resource-
limited countries are apparently still not receiving sufficient dietary folate.4 Therefore if these 
women continue to consume insufficient folate during pregnancy, their progeny will begin life 
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with a low store of folates, which tends to propagate the problem of intergenerational folate 
deficiency ad infinitum. Yet, the contemporary literature is rife with reports from resource-
limited countries that folate deficiency is less common than previously thought, and is rare, even 
among vulnerable populations that chronically consume a low-folate diet. What are the sources 
behind this bold conclusion? 
There are well known limitations in use of the serum folate concentration as a biomarker 
for diagnosis of folate deficiency among subjects with vitamin-B12 deficiency and/or hemolytic 
diseases like malaria.1,5,6 Thus, an intracellular metabolic block in folate utilization during 
vitamin-B12 deficiency results in raised serum folates which return to baseline only after vitamin-
B12 replacement; therefore the finding of a normal serum folate level in such patients with 
untreated vitamin-B12 deficiency can underestimate the extent of tissue folate deficiency. 
Similarly, hemolysis of red cells that accompanies malaria also releases the extant 30-fold higher 
erythrocyte folate concentration into plasma, thereby raising the serum folate level; this too can 
mask true folate deficiency.  
A central tenet of this review is that without sufficient consideration of the limitations of 
the serum folate concentration in the presence of coexistent vitamin-B12 deficiency and/or 
malaria in resource-limited countries, several investigators have categorically interpreted the 
results of a normal serum folate level as signifying a normal folate status. As a consequence, they 
have erroneously eliminated folate deficiency from consideration particularly among vulnerable 
populations of women and children who reside in these regions where a chronically poor folate 
intake is the norm. This potentially serious error from a few influential publications has led to a 
‘snowball effect’ where continued repetition [of this error] by these and other investigators (from 
many disciplines of medicine) has led to the widespread conclusion that folate deficiency is rare 
in those very populations that urgently need folate supplementation.   
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Since it is so important not to miss the diagnosis of folate deficiency particularly among 
women and children1,6,7—and analysis of the literature will show this has likely been the case—
the rationale for this review is to identify the genesis of how this error entered the literature, and 
then point to evidence from alternate sources that provides a sufficiently robust challenge to 
reverse this misconception.  
The approach of this narrative review will be: (i) To provide a historical perspective on 
data from seminal papers which identified how associated conditions like vitamin-B12 deficiency 
and/or hemolysis predictably gave abnormal test results for serum folates [or erythrocyte 
folates]; (ii) to identify those high-profile papers from resource-limited countries that have likely 
misinterpreted the results of normal serum folate levels in the presence of these confounding 
variables (vitamin-B12 deficiency and/or malaria), leading to an underestimation of folate 
deficiency; and (iii) to note how amplification of this error, through repetitive citation, has 
become embedded as ‘a fact’ in the current medical literature. (iv) Where there is a paucity of 
information in the literature, an attempt has been made to frame the key questions that need to be 
resolved. Finally, (v) where interpretation of non-invasive and invasive tests remains problematic 
or ambiguous, the imperative for prophylaxis is discussed within the context of the geographic, 
socio-economic, and dietary history of vulnerable populations.  
Search strategy and literature selection criteria. Data for this review was obtained by 
searching PubMed for all available articles published in English (up to August 2015), which 
contained any two of the following search terms “folate deficiency”, “vitamin-B12 deficiency”, 
“pregnancy”, “malaria” or “hemolysis”. The choice of articles that were subsequently reviewed 
in more detail was then based on four additional [inclusion] criteria: First, whether these articles 
were among the high-profile papers that originated the premise that folate deficiency was rare in 
resource-limited countries based primarily on the test results of serum folate levels. Second, the 
  
5 
studies were conducted in populations where there was no consumption of folate-fortified food 
or multivitamins. Third, whether there were source documents from other contemporary studies 
or other disciplines that provided insight into the prevailing nutritional or social context of these 
populations, and if such documents pointed to a high likelihood of coexisting nutritional vitamin-
B12 deficiency and/or malaria. Fourth, if such revelations allowed for a sufficiently strong 
challenge to seriously question the veracity of the earlier conclusions.  
Shortcomings in the diagnosis of tissue vitamin deficiency when blood tests for vitamin-B12 
and folate are solely used — the importance of clinical details. In several papers analyzed in 
this review, studies on the vitamin-B12 and folate status of subjects in resource-limited countries 
were conducted in the absence of clinical details. Such studies are incomplete because they fail 
to provide information on dietary intake or other clinical symptoms and/or signs, and on whether 
there is associated megaloblastic anemia (reflective of tissue deficiency of either vitamin-B12 or 
folate) and/or neuropsychiatric abnormalities (reflective of tissue deficiency of vitamin-B12). 
Such information is important because it is well established that even when subjects with 
vitamin-B12 deficiency are ambulatory, megaloblastic anemia can be present without major 
symptoms. For example, it is not uncommon for subjects in India and African countries to be 
fully ambulatory with megaloblastic anemia and hemoglobin levels of 9-10 grams/deciliter (or 
lower) with minimal to no symptoms; this is because the body has compensated over the long 
duration it takes to develop vitamin-B12 deficiency.1,6,8 Such symptoms can often be only elicited 
by leading questions in conjunction with a comprehensive physical examination1,9. Moreover, 
among ambulatory subjects with biomarkers that suggest vitamin-B12 deficiency, it may even 
require sophisticated neurological testing to reveal evidence for subtle abnormalities that reflect 
tissue deficiency of vitamin-B12.10-12 It should be noted that in resource-limited countries, apart 
from a primary dietary deficiency of folates, when vitamin-B12 deficiency is prolonged, 
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megaloblastosis of the intestinal cells can also predispose to a secondary malabsorption of [the 
already meager intake of] dietary folate; this can lead to folate deficiency developing late in the 
course of vitamin-B12 deficiency.8,13 Therefore in the absence of clinical data, the extent of tissue 
deficiency of vitamin B12 deficiency and/or folate cannot always be definitively ascertained 
merely from the serum level.1,6,8  
Limitation of the serum folate biomarker in the setting of vitamin-B12 deficiency — a 
historical perspective. In the early days, microbiological assays using bacteria that thrived on 
folate for their growth were used to measure the serum and erythrocyte folate concentration. 
Using such assays, hematologists in North America and the United Kingdom established that 
patients with anemia due to folate deficiency had low serum and erythrocyte folate 
concentrations (Table 1); this made it a useful standardized and objective measure in the clinical 
assessment of folate status in patients with anemia. However, when these investigators searched 
for other clinical conditions that could consistently raise the serum folate concentration, they 
found two confounding variables: i) patients with vitamin-B12 deficiency, and ii) hemolysis of 
red blood cells. Thus, as early as 1962, among 100-consecutive patients with pernicious anemia, 
megaloblastic anemia, and a low serum vitamin-B12 less than 100-pg/ml, Herbert and Zalusky 
identified that “one-third with vitamin-B12 deficiency had falsely high serum folate levels”.14 
These pioneers were remarkably prescient in their suggestion that in the presence of mild-to-
moderate tissue folate deficiency, the serum folate would be in the normal range in the presence 
of vitamin-B12 deficiency. Likewise Waters and Mollin15 observed in 1963: “The highest serum 
folate (L. casei) levels were found in patients with the lowest serum vitamin-B12 levels. As the 
serum vitamin-B12 level increased there was a progressive fall in the serum folate level…” In 11-
patients, they observed “[a] rapid fall in the mean serum folate level to approximately a third 
(34%) of the pre-injection mean during the first 24 hours after an injection of 1000-μg of 
  
7 
vitamin-B12”.15 Thus, if the serum folate concentration was at a low-normal range at baseline 
(prior to vitamin-B12 injection), the subsequent reduction in serum folate levels after vitamin-B12 
could easily have dropped into a folate-deficient range.  
Indeed, a year later, Cooper and Lowenstein16 documented a predictable movement of 
previously high serum folate values towards lower [baseline] levels in all 10-patients with 
pernicious anemia following correction of vitamin-B12 deficiency. Similarly, after vitamin-B12 
replacement of 15-Indian children (aged 6-months to 12-years) who were suffering from 
nutritional anemia due to vitamin-B12 deficiency,17 the serum folate concentration dropped in 6 of 
15-patients (40%) from previously normal values (mean of 17·6-ng/ml) to a deficient level with a 
mean of 4·8-ng/ml (their cut-off values for folate deficiency were less than 6-ng/ml)18; this 
suggested that this cohort likely had associated masked folate deficiency. In addition, among 5 of 
15-patients, serum folates remained persistently low even after vitamin-B12, consistent with 
associated overt severe folate deficiency. Thus, whereas 11 of 15-patients (73%) of these 
children actually had a combined vitamin-B12 plus folate deficiency, a full 40% of patients with 
folate deficiency would have been missed if only a single serum folate test value was available. 
[This is an important point because we will shortly see how other clinical investigators in 
resource-limited countries have erroneously made the diagnosis of ‘pure’ vitamin-B12 deficiency 
from only a single blood test result (that revealed a low serum vitamin-B12 but normal folate 
levels), which has likely missed significant numbers of patients with associated folate deficiency 
(Table 1)].  
Nixon and Bertino19 then determined that accumulation of serum folate in patients with 
vitamin-B12 deficiency (pernicious anemia)—and its fall after treatment with vitamin-B12—involved 
decreased clearance, reduced cellular metabolism, and increased renal excretion of 5-methyl-
tetrahydrofolate. These results were consistent with the "methyl-folate trap" hypothesis—reflecting 
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poor utilization of folate during vitamin-B12 deficiency to explain why hematological 
manifestations of vitamin-B12 deficiency resembled folate deficiency (Figure 1). Parenthetically, 
Nixon and Bertino19 also predicted that administering folate to vitamin-B12-deficient subjects would 
lead to “a several-fold elevation of the total serum folate concentration…” Indeed, fifteen years 
later, among a cohort with vitamin-B12 deficiency, Stabler et al20 documented that those consuming 
folate-rich multivitamins had the highest recorded serum folate values.  
Is there a threshold whereby there is a failure in maintaining the inverse relationship 
between low serum vitamin-B12 and higher serum folate? Thus far, we have considered the close 
relationship between a low serum vitamin-B12 level and an inverse rise in serum folate level among 
subjects with clinical findings of anemia attributable to vitamin-B12 deficiency. Whether such an 
inverse relationship holds throughout the spectrum of severe-, moderate-, and mild- vitamin-B12 
deficiency, or there is a particular threshold level (such as in mild serum vitamin-B12 deficiency 
when megaloblastic anemia has not yet manifested clinically) where this inter-relationship is not 
sustained, is not known. However, it is well established that the metabolic effects of vitamin-B12 
deficiency that lead to a functional (and later real) intracellular functional folate deficiency21 always 
precede the morphological manifestations of megaloblastic anemia.1,6,8  Therefore it would appear 
that this inverse relationship in serum vitamin-B12 and folate levels would hold firm even in mild-
to-moderate vitamin-B12 deficiency, and occur even before clinical findings of nutritional anemia 
were manifest. This is consistent with the earlier clinical observations15 and the dynamic changes in 
serum folate upon replenishment of vitamin-B12.17 This is an area for future investigation. 
Red blood cell (RBC) folates as a measure of folate stores — a historical perspective. Unlike the 
serum folate, which is entirely 5-methyl-tetrahydrofolate, RBC folates consist of a heterogeneous 
mixture of different coenzyme forms with varying polyglutamate chain lengths. Clinical 
measurement of RBC folates took on importance when tissue folate deficiency was clinically 
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correlated with a decrease in RBC folate (less than 150 ng/ml) by a microbiological assay in the 
60's22. Thus finding a decreased serum and RBC folates with megaloblastic anemia was consistent 
with the diagnosis of folate deficiency. Although this seemed like the ideal combination to diagnose 
folate deficiency, RBC folate tests had major limitations in sensitivity and specificity8,23,24, and were 
notoriously unreliable in alcoholics and in pregnancy; thus, it was normal/borderline in 
approximately 30% of alcoholics23 and 60% of pregnant patients25 with clinically significant folate-
deficient megaloblastic anemia. Furthermore, a reduction of RBC folate also occurs in 
approximately 60% with vitamin-B12 deficiency, further limiting its diagnostic utility.8 
 There is a further twist to this issue: the original microbiological assays for RBC folates 
have been replaced by radioassays currently used for measurement of serum folate levels. Apart 
from a lack of clinical validation of the use of radioassays for measuring RBC folates, these 
radioassays have had a long history of being unreliable with respect to lack of precision and 
accuracy, generally leading to a lack of confidence in the results.26 In addition, a quality 
assurance study from Australasia involving 134 laboratories identified nine (operator 
controllable) factors which could also lead to poor RBC folate results.27 And later analysis of its 
clinical value led to the conclusion that the RBC folate test added little useful information to that 
provided by serum folate levels.28 Together, these clinically relevant issues have considerably 
dampened enthusiasm for use of RBC folate tests, leading several experts to entirely avoid their 
use pending a resolution of problems related to reagent batch quality control, quality assurance, 
and equally important, provision of data on clinical validation by the various manufacturers of 
these kits. 
Therefore because of intrinsic problems of poor validation and unreliability, commercial 
RBC folate assays are not routinely used in the clinical diagnosis of folate deficiency1,29; so now, 
serum folates are primarily used for population-wide assessment of folate status in resource-rich 
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settings30-32 as well as for routine clinical diagnosis of folate deficiency.1,6 However, as noted 
above, the serum folate test has limitations in resource-limited populations where consumption 
of both vitamin-B12 and folate are poor.  
Clinical use of sensitive metabolite levels to diagnose vitamin-B12 and/or folate deficiency — 
a historical perspective. By the late 1980’s, the combination of serum homocysteine and serum 
methylmalonic acid tests were introduced clinically as far more sensitive diagnostic markers of 
vitamin-B12 deficiency than measurement of serum vitamin-B12 concentrations.20,33 However, it 
should be noted that the serum homocysteine is also increased in folate deficiency6,20,33 (Table 2). 
Therefore although high serum homocysteine and methylmalonic acid levels can reflect 
underlying vitamin-B12 deficiency, a combined vitamin-B12 plus folate deficiency cannot 
possibly be ruled out by a single set of tests6,20,33; see Table 1 and Table 2. Indeed, the only way 
to prove that a patient has pure vitamin-B12 deficiency involves a laborious, costly, and 
impractical approach of serial reassessment of both the serum homocysteine and methylmalonic 
acid values after vitamin-B12 replacement. Thus, with pure vitamin-B12 deficiency, both serum 
homocysteine and methylmalonic acid should drop completely into the normal range; however, 
if folate deficiency was also present, although the serum methylmalonic acid concentration 
would normalize, the serum homocysteine would not completely drop into the normal range.34 
Needless to state, except for isolated exemplars35, such detailed studies using metabolites20,33 
have not been reported among large cohorts of subjects from resource-limited settings. But by 
the same token, any study purporting to having diagnosed patients with ‘pure’ vitamin-B12 
deficiency—(using evidence from a single blood test showing low serum vitamin-B12 and normal 
serum folate values, and/or combined elevated serum methylmalonic acid and serum 
homocysteine values)—cannot have unambiguously ruled out an associated folate deficiency, 
particularly in resource-limited settings where dietary folate intake is persistently inadequate. 
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Yet, many high-profile studies have made precisely such claims, as discussed below.       
Masking of folate deficiency with coexistent vitamin-B12 deficiency   
1. Non-pregnant adults in India. When Refsum et al36 evaluated an ambulatory population in 
Pune with a single set of blood tests (without dietary or clinical information), they reported that 
47% had serum vitamin-B12 values that were consistent with vitamin-B12 deficiency (less than 
150-pmol/L), but apparently less than 5% had evidence of folate deficiency based on serum 
folate levels (less than 5-nmol/L). In addition 77% had hyperhomocysteinemia (more than 15-
μmol/L) and 73% had elevated serum methylmalonic acid (more than 0·26-μmol/L). On this 
basis, these investigators correctly concluded that vitamin-B12 deficiency was widespread among 
three-quarters of the population studied. However, their conclusion that folate deficiency was not 
a major problem is incorrect36 because only a single blood sample was assessed, and intentional 
studies designed to specifically unmask associated folate deficiency—by longitudinal 
measurement of serum folate values before and after vitamin-B12 replacement16,17,34—were not 
conducted. Because homocysteine is elevated in both vitamin-B12 and folate deficiency, these 
investigators did not unambiguously rule out an associated folate deficiency; this could have 
been shown out by first demonstrating a failure to drop the serum homocysteine into the normal 
range after vitamin-B12 therapy, and then confirming a further drop in serum homocysteine into 
the normal range only upon addition of folate replacement]. Therefore, Refsum et al36 have not 
unambiguously ruled out a combined vitamin-B12 plus folate deficiency.37 Because the average 
serum folate was 12·2-nmol/L [or 5.38-ng/ml] (i.e., in the low-normal range of the assay which 
had an upper limit of approximately 45-nmol/L)—and based on the potential for masking of 
folate deficiency during vitamin-B12 deficiency15-19,22—it is quite possible that vitamin-B12-
replenishment could have led to either a drop of serum folate concentrations below the lower 
limit of normal, or an incomplete drop of homocysteine into the normal range. Indeed, a 
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subsequent study from this region provided precisely such evidence to support the possibility of 
an associated folate deficiency38: Thus, in a small subgroup of non-pregnant women from Pune, 
following replacement with alternative days of 500-μg oral methyl-vitamin-B12 over 6 weeks,38 
these investigators observed: “Normalization of tHcy [total serum homocysteine] was obtained 
in only 4/11 women, while seven women continued to be hyperhomocysteinemic despite 
improvement of vitamin-B12 status within ‘normal’ range and despite a normal folate status.” 
However, the serum folate value of those women believed to have “a normal folate status” was 
actually in the borderline low-normal range, with a median value of 4.4-ng/ml at baseline (25%, 
75th centile = 2.4- and 5.8-ng/ml, respectively, with a cut-off value of less than 3.0-ng/ml 
signifying frank folate deficiency).38 Therefore women at the ‘25th centile’ clearly had laboratory 
evidence of folate deficiency, whereas many others had values in the low-normal range; and 
because they were not replenished with folate, their serum homocysteine likely failed to drop 
into the normal range, as would be predicted in a population with combined low vitamin-B12 and 
folate status. Equally revealing was the finding that “green leafy vegetables did not alter the 
serum folate or tHcys [total serum homocysteine]”.38 This reflects the well-known low 
bioavailability of folate in such foods after cooking.1,39 The existence of nutritional folate 
deficiency among these women should not be surprising because this predominantly vegetarian 
and near-vegetarian7,37 population subsists on well-cooked lentils, beans, and vegetables and only 
small portions of dairy (yogurt/milk), occasional eggs and seasonal fruit; moreover fresh salad 
greens are not customarily consumed. Even the non-vegetarian population consumes a similar 
diet as vegetarians but with the inclusion of only small portions of curried meats—at most twice 
a week.7,37 Therefore, in analogy to the data from Saraya et al17 in Indian children, there were a 
number of adult women in the study by Yajnik et al38 who were already folate-deficient; this fact 
could prevent a rise from preexisting low levels (following vitamin-B12 replacement) into the 
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normal folate range as had been previously observed in Indian children.17  While one cannot state 
with certainty—because intentional longitudinal replenishment studies have not been carried 
out—when taken together, these issues support the likelihood that the population studied in 
Pune36 had many more patients with combined vitamin-B12 and folate deficiency37 than the 
publication originally suggested. Yet the repetitive misinterpretation of findings of a single 
normal serum folate level as ruling out folate deficiency in this population36 has evolved over the 
years into a much more definitive assertion—as exemplified in this abstract40: “Two thirds of the 
mothers had low vitamin B12 concentrations, folate deficiency was rare, and high circulating 
concentrations of homocysteine predicted IUGR” [Italics mine]. It cannot be overemphasized 
that such a conclusion from this dedicated nutrition group in India is both erroneous and 
misleading to less specialized healthcare givers at large. [Parenthetically, prospective 
longitudinal follow up after individual serial vitamin-replacement can unambiguously answer the 
question of the frequency with which the serum folate can fail to rise into the normal range in 
such populations with combined vitamin-B12 and folate deficiency]. 
2. Pregnant women in India. Folate deficiency during pregnancy arises from a combination of 
poor dietary folate intake, increased requirements for maternal-fetal growth, and increased 
losses.1,6 The majority (more than 90%) of women of reproductive age in resource-limited 
countries (from sub-Saharan Africa, South and South East Asia, and Latin America) consume 
less than the estimated average requirement of folate,4 which predisposes them to folate 
deficiency before, during, and after pregnancy. By the late 1960s using microbiological blood 
tests for serum folate, folate deficiency was diagnosed among 85-100% of Nigerian,41 up to 80% 
of Canadian42 and 73% South Indian women43 in the third trimester of pregnancy. 
Parenthetically, if these South Indian women also had metabolic evidence of vitamin-B12 
deficiency—which we now know to be a worldwide problem7,33,36,37,44—the finding of a below-
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normal serum folate concentration in these women would actually reflect severe tissue folate 
deficiency.  
But do South Indian women consume less folate then their sisters in North India? The 
estimated dietary intake of folate among women in Northeastern and Eastern States in India is 
only 75- to 168-μg/day45; these values range from one-fifth to one-third of the optimum needed 
to prevent neural-tube defects.1,6 Despite these facts, among 283-pregnant women (one-half who 
were less than 22-years old) from rural Haryana in North India, 68% had iron deficiency, 74% 
had vitamin-B12 deficiency, but only 26% apparently had folate deficiency based on blood tests.46 
The implied conclusion was that vitamin-B12 deficiency is more of a threat than folate 
deficiency.46 But since vitamin-B12 deficiency was also present, many of those women with mild-
to-moderate tissue folate deficiency could be expected to have serum folate concentrations in the 
‘normal’ range.17 An earlier study from this region47 noted that “the consumption of food groups 
rich in micronutrients (pulses, vegetables, fruits, nuts and oil seeds, animal foods) was 
infrequent”; that “99% of these women consumed less than one-half of the recommended folic 
acid”46; that “over 19% pregnant women were consuming less than 50% of the recommended 
calories”,47 and 60% of pregnant women consumed less than 75% of recommended daily caloric 
allowance “indicating an overall poor food intake”.46 Such levels of poverty strongly correlate 
with and support the likelihood of low-folate status.1,6 Moreover, the state of Haryana is adjacent 
to Delhi—where both affluent city-folk and neighboring slum-dwellers were also documented to 
have equally poor dietary intake of folate and vitamin-B12, with high homocysteine values of 23- 
to 25-μM among 88% of study subjects.48 Again, such results were likely due to a combination 
of folate plus vitamin-B12 deficiency because more than 90% of both groups consumed less than 
one-fifth of optimum folate, and more than 75% consumed less-than-optimum amounts of 
vitamin-B12 daily.48 Therefore it is likely that many of those pregnant women from rural Haryana 
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46 had a combined vitamin-B12 plus folate deficiency (with the latter masked by extant vitamin-
B12 deficiency). So it should be stressed that folate deficiency is pervasive among women in both 
South and North India.  
These case studies illustrate how the use of biomarkers of serum folate without due 
consideration of the prevailing nutritional intake of folate and vitamin-B12 has led to a systematic 
de-emphasis of the issue of masked folate deficiency (within the context of widespread vitamin-
B12 deficiency). This can continue to perpetuate the wrong concept that folate deficiency is not a 
serious problem among women residing in resource-limited countries. Moreover, any consequent 
reduction in vigilance over the need for folate supplements for young girls well before they 
become pregnant has the dangerous potential to perpetuate maternal folate malnutrition with 
serious consequences to maternal-child morbidity and mortality.49 
Limitation of the serum folate biomarker in the setting of hemolysis (malaria) — a 
historical perspective. In 1961, Waters and Molin50 observed: “[It] was found that varying 
degrees of hemolysis increased the folic acid activity from three to ten times that of 
unhaemolysed serum”. By 1966, Hoffbrand et al22 documented a 30-fold higher erythrocyte 
folate to serum folate ratio in normal individuals. Therefore profound hemolysis during the 
erythrocytic stage of Plasmodium falciparum, which infects erythrocytes of all ages including 
bone marrow orthochromatic erythroblasts,51 will release their 30-fold higher folates into 
serum.22 In vitro hemolysis can also occur during blood collection, transportation, or storage 
arising from inadequate resources and/or infrastructure in malarious areas.52,53  
Intravascular hemolysis of parasitized cells and hypersplenism induces a powerful 
stimulus for compensatory erythropoiesis,54,55 increasing basal erythrocyte-production rates (of 2-
million per second in humans) by 5- to 10-fold, leading to significant reticulocytosis. However, 
over 50-years ago, Herbert and Zalusky14 reported that reticulocytes are richer in folate than 
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mature erythrocytes; thus 26% reticulocyte-rich preparations had nearly 10-fold increases in 
folate content than 6% reticulocyte-poor preparations (i.e., 273-ng/ml versus 29-ng/ml, 
respectively). Parenthetically, the physiological basis for higher folate content of reticulocytes 
and erythroid precursors was determined over two decades later in my laboratory.56-58 Both 
reticulocytes and mature erythrocytes contained vestigial remnants of functional folate receptors 
that primarily mediated the uptake of folate into erythroid precursors within bone marrow.58 
Thus, in the presence of compensatory erythrocytosis and reticulocytosis associated with 
hemolysis, analysis of such reticulocyte-rich blood for erythrocyte folate content (RBC folate 
concentration) would yield high values; this could give a false impression of normal folate status, 
when in fact, the true folate status may be low because of a combination of poor dietary folate 
intake and increased folate requirements to support compensatory hematopoiesis (Table 1). (The 
extent of contribution to the red cell folate content from Plasmodium falciparum, which can 
synthesize folates in erythrocyte cultures in vitro59 and also raise erythrocyte folates in animal 
models with high levels of parasitemia,60 is unknown in humans). So measurement of the serum 
folate level in malaria during hemolysis of Plasmodium falciparum-infected erythroid 
precursors, reticulocytes, and mature erythrocytes, with release of folate-rich intra-erythrocyte 
contents (and an as yet unknown quantity of liver folate) into serum, would also provide 
misleading estimates of the patient’s folate status. In this context, there would be added 
complexity because repeated cycles of Plasmodium falciparum-induced hemolysis would release 
substantial amount of various forms of folate—i.e., 5-methytetrahydrofolate [monoglutamates] 
and folate polyglutamates of different glutamate chain lengths61—into the serum. Apart from the 
poor clearance of serum 5-methyltetrahydrofolate that is associated with vitamin-B12 deficiency19 
(Figure 1), polyglutamylated-folates are also inefficiently transported back into cells relative to 
monoglutamates.1,62 However, because the earlier microbiological assays for folate could not 
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discriminate between these various forms of folates22,50 a high serum folate would be reported in 
all these individuals (Table 1).  
Populations living in resource-limited malarious regions of Asia and Africa often suffer 
from food insecurity, which predicts for poverty-imposed near-vegetarianism1,6,7; this involves 
consumption of a monotonous, largely vegetarian or vegan-like diet that is low in folate, iron, 
and vitamin-B12.7,37,44,63 Here too, the coexistence of vitamin-B12 deficiency in these populations 
will also raise the serum folate concentration. 
There is no prior human data that has systematically evaluated the effects of repeated 
cycles of Plasmodium falciparum-induced hemolysis on serum folate levels; however, given the 
longstanding mandate of administering prophylactic folate supplements for all patients with 
hemolysis,1,6 it would be unethical to prospectively conduct such studies. Nevertheless, because 
evidence—(i.e., 30-fold higher erythrocyte folate; hemolysis of folate-rich erythrocytes, 
reticulocytes, and orthochromatic normoblasts during the erythrocytic phase of malaria; and 
associated vitamin-B12 deficiency)—does compound,64,65 there is a high probability that in 
resource-limited settings associated with food insecurity-imposed inadequate vitamin-B12 and 
folate intake, a patient with profound hemolysis from Plasmodium falciparum malaria will still 
have an artificially high [or normal] serum folate concentration despite extant nutritional [tissue] 
folate deficiency. 
With this background, we are in position to critically evaluate the veracity of conclusions 
from influential studies that measured serum folates in African children with malaria and/or 
vitamin-B12 deficiency and [erroneously] concluded that folate deficiency is uncommon, even 
though their diet was severely compromised by dire poverty and/or famine. 
Masking of folate deficiency by malaria (and probable nutritional vitamin-B12 deficiency) 
(i) Children in The Gambia. Abdalla et al66,67 observed that “the serum and red cell folate levels 
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were above the lower limits of normal” among 75 of 106-Gambian children less than 5-years 
with acute uncomplicated Plasmodium falciparum malaria and variable degrees of anemia. These 
investigators therefore concluded that folate deficiency was not likely given these laboratory 
values. Unfortunately however, they failed to make connections between the potential for 
malaria-induced hemolysis and reticulocytosis to raise the serum and red cell folate 
concentration independently of the folate status of these children. But were these children well 
nourished and consuming a well-balanced diet that was rich in folates? To the contrary, historical 
records68 reveal that there was a very high likelihood of severe food insecurity in The Gambia 
during this period. For example, Abdalla et al conducted their series of studies during harsh, 
recurrent droughts of the 1970’s and 1980’s (known as the [African] ‘Sahel Desiccation’) that 
included The Gambia, which resulted "…in massive losses of agricultural production and 
livestock; loss of human lives to hunger, malnutrition and diseases; massive displacements of 
people and shattered economies”.68 So there was evidence of severe food insecurity, which 
predisposes to poor dietary intake of micronutrients (folate plus vitamin-B12) and iron.7,37,44,63 Yet, 
without considering a) the high red cell folate concentrations in reticulocyte-rich blood, or b) the 
role of hemolysis of Plasmodium falciparum infected erythroid precursors, reticulocytes and 
erythrocytes in increasing the serum folate, or c) the likelihood of associated dietary vitamin-B12 
deficiency in artificially raising the serum folate,22,50,52,53 or d) the need to provide folate to 
support compensatory hematopoiesis (the prevailing dictum8,13), or e) the extant poor nutritional 
status of these children, these investigators (hematologists) did not recommend folate 
supplements. As a result, other clinicians and nutritionists have been misled by a fallible 
laboratory test over other indicators of folate deficiency. These influential studies66,69-71 have led 
to an across-the-board conclusion that tens-of-millions of other children with chronic hemolysis 
from repeated episodes of malaria and a poor dietary intake of folate do not have folate 
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deficiency.71,72 Equally surprising, is the fact that innumerable papers and authoritative reviews 
on anemia in malaria73,74 have not even considered the likelihood of poor micronutrient intake as 
a contributing factor to anemia in these populations. As a consequence, there has been no 
mandate from the medical establishment for giving such children folate despite their likely need 
of this vitamin. 
 (ii) Children in Malawi. In a high-profile paper, Calis et al75 found severe anemia in Malawian 
children where malaria was found in 60% and vitamin-B12 deficiency in 30% “[but] folate and 
iron deficiencies are not prominent”. In response to the issue of extant poor diet, poor test-
sensitivity, and hemolysis in underestimating folate deficiency [raised in correspondence76], the 
authors acknowledged: “[It] is theoretically possible that hemolysis and vitamin-B12 deficiency 
have masked folate deficiency…. We did not evaluate the source of dietary-folate intake in these 
children in detail, but green vegetables and fruits account for a large proportion of the dietary 
intake of children in Malawi…”.75,76  
However, this rosy dietary assessment among children in Malawi—the seventh poorest 
country in the world—is contradicted by reports from three different sources that highlight the 
nutritional status of the population at that time: 
(a) A Food and Agriculture Organization report,77 which highlighted two drought-
induced famines in the 1990s and in the year immediately preceding and following the 2002-
2004 study by Calis et al,75 concluded with a poignant description of serious malnutrition among 
Malawian children less than 5-years—the age group studied75: “…[p]overty and food insecurity 
explain the very high prevalence of chronic malnutrition that plagues Malawi, almost half of the 
children under-five years being stunted… Micronutrient deficiencies are widespread…. The 
nutritional status of the Malawian population remains critical”.77  
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(b) An earlier study on the impact of malarial infection and diet on anemia in rural 
pregnant Malawian women in 1999 noted78: “Cereals, predominantly maize, provided more than 
75% of energy in their diets. Maize flour has a very low folate content (that is 25-μg/100-gm). It 
is consumed two to three times a day, often as a stiff porridge (nsima) with a cooked relish 
prepared from green leaves (for example pumpkin leaves) or legumes. However, because the 
traditional Malawian cooking practices involve protracted boiling, much of the folate in the 
cooked relishes is probably destroyed”.  
 (c) The intergenerational (mother-to-child) transmission of micronutrient deficiency has 
a profound impact on children. Among 150-anemic Malawian women predominantly in the third 
trimester,79 folate deficiency was found in only 34%, and vitamin-B12 deficiency in 33%—(80% 
of whom also had normal serum folates). However, a then-contemporary Malawian report in 
2000 noted the serious food insecurity and famine-like conditions of the nineties, and 
concluded80: “Young children and women of reproductive age are especially vulnerable to 
nutritional deficits and micronutrient deficiency disorders”. Because folate-rich foods are not 
easily available78 and consumption of folate supplements during socio-economic upheavals of 
famine are uncommon,1,6 it is quite unlikely that these Malawian women consumed a folate-rich 
diet sufficient to avoid folate deficiency during the third-trimester. So how can one explain the 
observed ‘normal serum folate levels’ among two-thirds of this pregnant population?79 Here, it is 
particularly significant that these authors noted79: “The diet of most women in our situation is 
effectively vegan”. Although such vegan diets are notoriously low in vitamin-B12 content 
mandating routine prophylactic vitamin-B12-supplementation,1,7,81-83 this was not routine practice 
in Malawi.79 Therefore, it is likely that a greater number of these Malawian women79 would have 
been diagnosed with vitamin-B12 deficiency if more sensitive [metabolite] studies of serum 
methylmalonic acid and homocysteine were used.7,33,36,44,63 And many more women with ‘normal’ 
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serum folate in that study79 likely had masked tissue folate deficiency. Such women would 
invariably pass down their own folate/vitamin-B12 deficiency to their babies, who continue to 
consume folate/vitamin-B12-poor breast milk35,84,85 before being weaned onto similar diets as their 
mothers.  
So how did those little Malawian children in the study by Calis et al75,76—who needed 
folate to support compensatory hematopoiesis and were in the midst of near-famine conditions in 
Malawi77,79—acquire folate and avoid folate deficiency if their mothers were not getting 
sufficient vitamin-B12 or folate? The body of evidence cited77-79 is contrary to the assertion that an 
abundant folate-rich diet consumed by those children can explain findings of ‘normal serum 
folate’ values in their patients.75,76 Yet, the conclusion that folate deficiency is not a problem in 
patients with malaria75 (which mimic earlier conclusions66,69-72) is now widely viewed as factual: 
The authoritative UpToDate® entry on ‘Anemia in Malaria’,74 which highlighted the work of 
Abdalla67 and Calis et al,75 concluded that folate deficiency is uncommon74: “Although dietary 
deficiencies are widespread in malarial endemic regions the influence of reduced folate levels 
[sic] are not thought to be major contributors to the dyserythropoiesis seen during severe malarial 
anemia.67 The finding of low vitamin B12 levels in malaria suggests that subclinical deficiency of 
B12 may play a hitherto unrecognized contribution to severe anemia…75”. —[Italics mine]. 
(iii) Children in Kenya. The case from Embu, Kenya, is instructive because both vitamin-B12 
deficiency and Plasmodium falciparum malaria were endemic in the region.86 Among children 
aged 5- to 14-years, 31% had serum vitamin-B12 levels less than 125-pmol/L (severe vitamin-B12 
deficiency) whereas 38% had serum vitamin-B12 values between 125-220-pmol/L (moderate 
vitamin-B12 deficiency). Although one-third had malaria, 45% had enlarged spleens (suggestive 
of chronic malaria re-infection). However, the prevalence of folate deficiency based on serum 
folate levels was almost zero! (The actual values for serum folate were between 20-46-nmol/L 
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with the upper value at the upper limit of the assay). Of significance, the potential role of 
vitamin-B12 deficiency or malarial-hemolysis in artificially raising serum folate (thereby masking 
an underlying folate deficiency) was not considered.    
Taken together, despite the known limitations of the blood tests for folate in the presence 
of vitamin-B12 deficiency and/or hemolysis accompanying malaria, there has been a consistent 
undue overreliance on these imperfect blood tests, even over the more reliable estimates from 
poor dietary folate intake and other clinical indicators of folate deficiency (discussed below). 
Because the results of such blood tests invariably trigger decisions for [or against] replacement 
therapy, the interpretation of results following the measurement of the serum folate level in these 
patients has, in all likelihood, resulted in the therapeutic decision to [continue to] withhold 
folates from these unfortunate women and children, thereby predicting an adverse outcome.  
Tracing the potential cognitive biases in medicine that may have led to propagation of an 
error in the literature. How could the medical establishment have a) ignored the well-known 
facts related to the masking of the serum test for folate deficiency in the presence of vitamin-B12 
deficiency and hemolysis accompanying malaria? And b) fallen prey to the false concept that 
folate deficiency is rare in resource-limited countries where dietary intake of folate and vitamin-
B12 is poor, and anemia and malaria is endemic? Here we must confront our collective cognitive 
biases that have likely led to perpetuation of the medical myth exposed in this article.  
Whenever a high-profile paper in the literature downplays key results from earlier papers, 
subsequent papers tend to highlight the more recent paper and exhibit “recency bias”, wherein a 
disproportionate importance is given to more recent observations and conclusions.87 This has, 
and will in turn, lead to an “availability bias/cascade”—a self-reinforcing process87 wherein the 
collective beliefs of researchers appears more and more plausible through repetition of the same 
fact over and over again in high-profile journals. [Even Kipling’s Bandar-log had a similar 
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slogan: “We all say so, so it must be true”88]. Intrinsic to the process of dissemination of medical 
information is the “framing effect”, which (in the context of this paper) involves drawing 
different conclusions from the same information in a dataset, depending on the author’s choice of 
presentation.87 So when a normal-to-increased serum folate level is observed in vitamin-B12 
deficiency, the potential of masked folate deficiency has been ignored.36,46 Likewise the findings 
in Gambian and Malawian children with malaria and normal-to-high serum folate levels have 
subsequently led to broader conclusions that almost all African children with malaria do not have 
folate deficiency.89 Then, as more and more experts from several diverse specialties—including 
obstetrics,90 nutrition,36 infectious disease,91 internal medicine,92 pediatrics,69,93 cardiology,94 
endocrinology,95 epidemiology and public health,92 and even hematology72,73—studied 
populations at risk for both vitamin-B12 deficiency and malaria without sufficient consideration 
of all clinically relevant data including the dietary history, they referenced those papers that 
supported their own observations, and viewed the results from these cohorts through the narrow 
lens of their individual specialty. This reflects a “confirmation bias”— the tendency to search for 
or interpret the information of their own research in a way that confirms earlier preconceptions.87 
When confirmation bias reaches epidemic proportions,87 this can lead to in-group bias; here 
reviewers of papers proffered to Journals can tend to preferentially accept those papers that 
reinforce the conclusions by several other members of their own group. Not surprisingly, further 
propagation of the concept among groups of researchers (now reading similar journals) will 
invariably lead to a “bandwagon effect” where many more individuals believe the same thing87—
this is closely related to groupthink and herd behavior.87 The danger of groupthink is particularly 
germane to various reviews or even consultations periodically held by major agencies (e.g., 
National Institutes of Health, World Health Organization, & Etc.) to generate “White Papers” on 
state-of-the-art. Minimization of controversy or conflict within this construct can fail to critically 
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assess the data that led to the conclusions in the first place, with a group-wise failure in accepting 
any alternative proffered ideas, views, or concepts.  
Defining tissue folate deficiency in resource-limited countries — caveats and limitations. 
Because the liver parenchyma is the primary site for storage of folates1, depletion of the amount 
of folate in the liver indicates folate deficiency; however a liver biopsy is much too invasive a 
test for routine clinical use. Given the limitations in interpretation of serum folate tests in 
resource-limited settings (as discussed above), can a study of other clinically accessible tissues 
help to confirm deficiency and perhaps distinguish it from vitamin-B12 deficiency? Although the 
test for RBC folates (by microbiological assay) was a good surrogate test for pure tissue folate 
stores, the newer non-microbiological assays for RBC folates have not been as clinically reliable 
(as discussed above). Moreover, in the context of a patient infected with malaria there are 
additional problems in interpretation of RBC folates. This stems from the fact that the malarial 
parasite has a life cycle that involves both an erythrocytic and an exo-erythrocytic phase (in 
liver) that results in hemolysis of red cells and lysis of infected parenchymal liver cells, 
respectively. And parasites themselves can contribute an [incompletely characterized] amount of 
folate to infected red cells.59,60 This further limits the value of [serum and] RBC folates. So can 
an analysis of the bone marrow morphology [following a bone marrow aspirate/biopsy] identify 
megaloblastic anemia associated with folate deficiency? Yes, provided there are no other 
confounding variables. But in the case of associated malaria, information on the extent to which 
parasitic infestation per se modulates the morphological expression of folate deficiency in these 
tissues is limited to published data [on the morphology of bone marrow aspirates] from only a 
handful of children in The Gambia.66,67 Because such studies were carried out during famine 
conditions (the Sahel Dessication), these children were likely to have had varying grades of 
multiple combined deficiencies of minerals (predominantly iron, but also zinc, copper, and 
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selenium) and micronutrients (including folate and vitamin-B12, -A, -B1, and -B6). 
(Parenthetically the likelihood of multiple deficiencies in these children was not commented on 
in these publications).66,67 Collectively, these multiple deficiencies can be expected to 
significantly alter the morphology of folate-deficient megaloblastic anemia. As one example, we 
know that associated iron deficiency will significantly modify and mask the [expected] classic 
features of megaloblastic anemia (i.e., masked megaloblastosis)1; instead, finding other subtle 
manifestations of giant myelocytes and metamyelocyte and hypersegmented polymorphonuclear 
leukocytes are clues that can clinch the diagnosis. [Therefore preclinical studies that can 
precisely clarify the independent and combined impact of additional mineral and micronutrient 
deficiencies in modifying the expected features of megaloblastic anemia, and how this is further 
altered in malaria-infected bone marrow, are areas for additional study]. Finally, merely 
identifying megaloblastic anemia cannot distinguish between folate or vitamin-B12 deficiency.1 
Thus, the challenge to unambiguously diagnose single deficiency of folate or vitamin-B12 from 
combined vitamin-B12 and folate deficiency necessarily rests on the cumbersome and expensive 
serial measurement of metabolites (methylmalonic acid and homocysteine) after specific 
replacement of the deficient vitamin (as discussed above).  But by the same token, mere use of a 
single metabolite test result to exclude the coexistence of folate deficiency warrants far greater 
caution in interpretation than exhibited in the publications cited.    
Alternative methods for assessing folate status in resource-limited settings. Dietary 
assessment using a variety of methods (24-h recall, estimated/weighed record, or locally 
validated food-frequency questionnaires96-98) are established methods to evaluate the quality of 
food and quantity of nutrients consumed by individuals in an ethnically homogeneous area.4,99 
Despite intrinsic limitations, these methods can predict with fair reliability the dietary folate and 
vitamin-B12 intake of a larger population consuming similar foods, and identify those at risk for 
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nutritional insufficiency.4,45,48,96-98,100 These approaches allow for the conclusion that there is 
inadequate dietary-folate intake and widespread folate deficiency throughout India, which is also 
associated with both iron and vitamin-B12 deficiency.35,45,48,96,101 Such information contributed to 
raising the recommended dietary allowance for folate intake in India to 250-μg/day in 2010.102 
Similar approaches can be used in other resource-limited countries.  
On the consequences of underestimating poor folate status in women and children. Anemia 
is the most common clinical manifestation of a deficiency of iron-, folate-, and vitamin-B12 (in 
various combinations); is widespread among children, adolescents, and women throughout 
India103,104; is believed to be among the highest in the world101,105,106; and can lead to serious 
maternal morbidity and mortality.49,107-110 Likewise, the relatively monotonous diet of women and 
children and the accompanying food insecurity in Africa—in Kenya,97,100,111,112 Malawi,77,78,80 and 
The Gambia68 that predisposes them to clinically significant deficiencies of iron, folate and 
vitamin-B127,37,44,63—also manifests as widespread nutritional anemia.103 In this context, it should 
be noted that attempts to replenish either iron and/or vitamin-B12 without addressing existing 
folate deficiency would invariably result in persistent anemia. 
Although there are many causes for neural-tube defects, the vast majority of these defects 
can be prevented by periconceptional folate supplements1,6,113-115 with greater protection (up to 
70%) afforded when the incidence of neural-tube defects is higher.114 Based on both preclinical 
studies116-119 and clinical trials113,114, the relationship between folate replacement and prevention of 
neural-tube defects fulfills Koch’s postulates on the causation of disease.120 Therefore the value 
of optimizing folate status is self-evident. But is this a problem in India? The only population-
based approach reported from a cluster of villages in North India discovered the incidence of 
neural-tube defects was 6·57- to 8·21- per 1000-live births,121 which is among the highest in the 
world. Although our study was from the least-developed area of India121, this region was 
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representative of 168 additional districts in India, and the incidence of neural-tube defects was 
similar to that recorded in tertiary centers from several major cities in North and South India122-
124; this somewhat validates extrapolation of the incidence of neural-tube defects to a much wider 
area in India.121 A recent systematic review has identified a birth prevalence of neural-tube 
defects in India of 4·1 per 1000-births,125 reflecting a largely silent epidemic of mammoth 
proportions.121,126 Therefore, using data from the lower and higher incidence of neural-tube 
defects (4·1- to 8·21- per 1000-births), and conservative estimates on potential prevention of one-
half of neural-tube defects with periconceptional folate supplements114—based on an estimated 
27-million annual pregnancies in India—there could well be between 55,000- to 110,000-births 
with neural-tube defects that can be prevented each year by optimizing folate status. This is a 
critically important opportunity for governmental leaders to rectify2 and thereby reduce the 
incalculable physical, psychological and economic burden for affected children and their 
families. 
(Despite the strength of the data underlying the prevention of neural-tube defects with 
folate supplementation, because of the close metabolic interrelationship between folate and 
vitamin-B12, it is possible—(but not yet unambiguously proven clinically)—that vitamin-B12 
deficiency will also be independently shown as a cause of neural tube defects.127 Clinical 
investigations into the potential role of vitamin-B12 deficiency as an independent risk factor in 
neural-tube defects—based on low vitamin-B12 levels in mothers of affected progeny—will 
necessarily need to rule out an associated [masked] folate deficiency. So despite the apparent 
high prevalence of vitamin-B12 deficiency, it is not yet possible to attribute a precise risk 
percentage of vitamin-B12 deficiency to neural-tube defects in India).  
Prophylactic administration of folate to women of childbearing age can prevent short-
term pregnancy complications (anemia, abruptio placenta, small-for-date babies, preterm birth), 
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as well as adverse short-term pregnancy outcomes for the newborn (low birthweight, midline 
birth defects).128 Recent studies from UK, Norway, Sweden, and India—where government-
mandated folate fortification of food is not in practice—also suggest that the progeny of women 
who do not consume folate supplements during the periconceptional period can exhibit subtle 
long-term adverse consequences in behavior during childhood.129-132 Parenthetically, these 
observations are the human correlates of earlier preclinical studies (in mice),133,134 which 
confirmed a relationship between gestational folate deficiency and abnormal neuro-pathology 
and neuro-development in utero. Our subsequent studies suggest a novel molecular basis for the 
aberrant activation of such neurological pathways in the fetal brain that experiences gestational 
folate deficiency; this involves the post-translational homocysteinylation of an mRNA-binding 
protein that abnormally modulates the expression of proteins that are involved in the biosynthesis 
of both neurotransmitters and neurons.1,6,135 This is yet another area that warrants additional 
study. 
Appropriate prophylaxis negates laboratory testing for folate deficiency. The mandate for 
folate supplementation of patients with hemolysis originally arose in the West, where despite 
consumption of an apparently folate-sufficient diet, patients with different etiologies for 
hemolysis often developed folate deficiency that led to an aplastic crisis.8,13 This hemolysis-
induced folate deficiency predictably arises from increased requirements to support 
compensatory hematopoiesis in the bone marrow and chronic loss of red cell folates into the 
urine and stool. Therefore a longstanding dictum in clinical hematology is that all patients with 
hemolysis from any cause must be given 1-mg folic acid/day to optimize hematopoiesis, because 
a failure to do so can precipitate a reticulocytopenic [megaloblastic] crisis.1,6 [Additional causes 
for hemolysis in patients with malaria that warrant routine folate supplements include: 
hemoglobinopathies that confer resistance to malaria (α- or β-thalassemia, sickle cell disease); 
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individuals with glucose 6-phosphate dehydrogenase-deficiency given primaquine, sulfadoxine, 
or dapsone for malaria; a Coombs-positive immune-mediated hemolysis; and sepsis-induced 
disseminated intravascular coagulation]. Parenthetically, and in this context, among populations 
where the dietary intake of folate, vitamin-B12, and iron is compromised, it is unknown how 
frequently the reticulocytopenia observed in Plasmodium falciparum-anemia74 can be reversed 
with folate plus vitamin-B12 plus iron supplements. As noted above, it is possible that other 
associated micronutrients and mineral deficiencies can profoundly alter hematopoiesis in the 
bone marrow. Nevertheless, there has been no controlled clinical trial that has unambiguously 
shown that such children did not benefit from replacement doses of folic acid administered with 
antimalarials after iron and/or vitamin-B12 deficiency is reversed. Therefore until such data is 
available, children suspected of having such micronutrient deficiencies ought to be given the 
benefit of such replacement. 
A related axiom in clinical medicine is that there is little point in performing any test if 
the result does not change one’s therapeutic decision. Therefore a relevant question is: “Why is it 
necessary to know the folate status of an individual with active malaria, since all such patients 
ought to be given folate to support compensatory hematopoiesis (together with antimalarials)?” 
Indeed, one can make a strong case that in clinical practice in resource-limited settings the use of 
blood tests to assess for folate status during hemolysis has no basis.  
But are there risks to administering folate supplements to support compensatory 
hematopoiesis in malaria? A recent meta-analysis of 19 studies have put to rest the concern of 
iron-folate and malarial progression136 and a Cochrane analysis identified no evidence that this is 
a problem when combined with antimalarial drugs and insecticide-treated bed-nets.137  
Although Plasmodium falciparum possess two folate transporter proteins that can 
facilitate membrane transport of folic acid, folinic acid, the folate precursor p-amino benzoic 
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acid (pABA), and the human folate catabolite pABAGn, rescue experiments on parasites in vitro 
show that pABA was the only effective salvage substrate at normal physiological levels.138 
Recently Van Eijk et al139 affirmed the safety of low-dose folic acid (1-mg/day) in 467-pregnant 
women with malaria; however, high-dose folic acid (5-mg/day) will allow for resistance, and 
have adverse outcomes in children.140-142  
Therefore given their propensity to have multiple deficiencies that continue into 
pregnancy, all non-pregnant women who require anti-malarial treatment143 should be treated for 
both malaria as well as iron, folate, and vitamin-B12 to enable optimal hematopoiesis. Likewise, 
all pregnant women living in resource-limited malarious areas malaria should routinely be given 
intermittent preventive treatment according to the latest guidelines (currently it is sulfadoxine-
pyrimethamine144) together with insecticide-treated bednets, plus 1-mg folic acid, prophylactic 
doses of 10- to 25-μg vitamin-B12 and replacement doses of iron orally.145 
Finally, optimizing the nutrition and general health of young women well before they are 
pregnant (i.e., intentional preparation for pregnancy146) is also the best way to ensure optimum 
transfer of nutrients to the developing fetus, and to nurture the baby after delivery. Indeed, this is 
the only way to curtail the inter-generational passage of these mineral and micronutrient 
deficiencies from mother to baby ad infinitum. 
Conclusion 
The repetition of a critical error involving the misinterpretation of a blood test result in the 
clinical literature in populations at risk for combined folate- and vitamin-B12- deficiency and/or 
malaria has led to a ‘snowball effect’ wherein paper-upon-paper has propagated the myth that 
folate deficiency is uncommon in resource-limited settings. As a result, millions of women and 
children with true [tissue] folate deficiency have probably not been given folate replacement. It 
is hoped that recognition and redress of such serious errors among women and children in these 
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resource-limited settings—that can be achieved by early prophylactic replenishment with 
micronutrients that include folate and vitamin-B12 (and key minerals)—will improve maternal-
child health and reduce the unacceptably high morbidity and mortality in these regions. 
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Legend to Figure 1: Vitamin-B12 and folate interrelationships: Normally, the tissue utilization 
of serum 5-methyl-tetrahydrofolate requires vitamin-B12 (as methyl-vitamin-B12 [also known as 
methyl-cobalamin]) to activate methionine synthase, a key enzyme that converts 5-methyl-
tetrahydrofolate to tetrahydrofolate, which is then polyglutamylated by folylpolyglutamate 
synthase (not shown in the figure). These folate polyglutamates are thereby retained in the cell 
and are the forms that participate in and perpetuate one-carbon metabolism. But with vitamin-B12 
deficiency, there is lowered activity of methionine synthase, which results in a functional folate 
deficiency wherein an increased amount of 5-methyl-tetrahydrofolate—(and homocysteine that 
is not methylated by methionine synthase to form methionine)—is trapped and accumulates 
within cells. Because 5-methyl-tetrahydrofolate is a poor substrate for folylpolyglutamate 
synthase, there is decreased synthesis of folate polyglutamates. As a result 5-methyl-
tetrahydrofolate (and homocysteine) leaks out of cells into blood.1,21 When vitamin-B12 
deficiency is prolonged, there is a real cellular folate deficiency arising from failure to retain 
folate within cells.21 This explains why patients with pernicious anemia and/or nutritional 
vitamin-B12 deficiency have normal to high serum folates (that can mask an associated mild-to-
moderate folate deficiency) and high serum homocysteine levels, and an initial functional 
intracellular folate deficiency that culminates over time in a true tissue folate deficiency, and low 
erythrocyte folates. 
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Table 1. Serum folates are Misleadingly Elevated in Vitamin-B12 Deficiency and/or Malaria 
Which Are Both Common in Resource-Limited Settings§* (From Ref. 6) 
 
     Serum folates              Erythrocyte folates                 Serum Vitamin-B12  
Pure Folate deficiency   Low              Low                  Normal/Low* 
 
Pure Vitamin-B12 deficiencyΨ   Normal/High*Ψ             Low*Ψ                  Low  
 
Folate plus Vitamin-B12 deficiency  Normal*              Low                  Low 
 
Pure Malaria    Normal*/High*ξ                  High*Φζ                              Normal 
 
Malaria plus Folate deficiency  Normal*              Normal*/High*/Low     Normal 
 
Malaria plus Vitamin-B12 deficiency  Normal*/High*ξ             Normal*/High*ζ                 Low 
 
Malaria plus Folate plus Vitamin-B12 deficiency Normal*/High*ξ             Low/Normal*ζ Ω                 Low 
 
* The asterisk indicates misleading values in the clinical settings shown on the left.  
§ Both vitamin-B12 deficiency and clinical malaria and other hemolytic states can complicate the diagnosis of folate 
deficiency using tests for serum- or erythrocyte- folate concentration.147  
Ψ Vitamin-B12 deficiency is accompanied by inability to utilize folates for one-carbon metabolism so folates leak out 
of erythroid precursors into serum.  
ξ Release of the 30-fold excess folate from infected erythroid precursors, reticulocytes, and mature erythrocytes 
during hemolysis raises serum folate levels. (An as-yet-unknown quantity of folate is released into serum when 
folate-rich hepatocytes are destroyed during the exo-erythrocytic hepatic phase of malaria).  
Φ Hemolysis induces a compensatory reticulocytosis; these reticulocytes are richer in folate than mature 
erythrocytes.14,56,58  
ζ Plasmodium falciparum can also synthesize folates in erythrocyte cultures in vitro59 and raises erythrocyte folates 
in animal models with high levels of parasitemia.60  
Ω Reticulocytopenia in severe Plasmodium falciparum malaria, due to either combined vitamin-B12 deficiency plus 
folate deficiency, which can trigger a reticulocytopenic (megaloblastic) crisis], or cytokine-induced inhibition of 
hematopoiesis, will negate an expected rise in erythrocyte folates.  
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Table 2. 
Interpretation of test results on serum methylmalonic acid and total homocysteine 
(adapted from Ref. 1) 
 
 
Methylmalonic Acid* Total Homocysteine§ ξ Diagnosis 
Increased Increased                                             Vitamin-B12 deficiency confirmed;  
                                                                                                                                                  folate deficiency still possible 
                                                                                                                                                   (i.e., combined vitamin-B12 plus 
                                                                                                                                                    folate deficiency is possible) ξ 
 
Normal Increased                                              Folate deficiency is likely                                                                                    
 
Normal Normal                                                  Vitamin-B12 and folate deficiency 
                                                                is excluded                                                                                                                                                            
* Methylmalonic acid (normal values = 70–270 nM) 
§ Homocysteine (normal values = 5–14 μM) 
ξ  In patients with combined folate plus vitamin-B12 deficiency, the serum homocysteine will not fall completely into 
the normal range unless both folate and vitamin-B12 are replaced.34 Less commonly, with pyridoxine 
deficiency, specific replacement with pyridoxine will be required before the serum homocysteine falls into 
the normal range.    
